BY KATHRYN WATSON
SEPTEMBER 8, 2023
Danco Laboratories, the drugmaker of the abortion pill mifepristone, has asked the Supreme Court to review a lower court's decision limiting access to the pill, the company announced in a news release Friday. On Friday evening, the Justice Department also asked the Supreme Court to review the Fifth Circuit's judgment.
Danco and the Justice Department want the Supreme Court to reverse the circuit court's ruling that would prevent women from obtaining the drug by mail order and would prohibit the pill after seven weeks of pregnancy.